Study S002822

A Multicenter, Randomized, Double-Blind, Placebo- Parallel Controlled, Phase III Study to Evaluate the Efficacy and Safety of HS-20094 Injection in Subjects With Type 2 Diabetes, Inadequately Controlled With Diet and Exercise Alone

ClinicalTrials.gov record

Registration

Registration: NCT07156500
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: QUADRUPLE
Status: NOT_YET_RECRUITING
Enrollment: 204
Start: 2025-09-30
Primary completion: 2027-03-30
Lead sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions: Type 2 Diabetes
Interventions: DRUG:HS-20094 Injection; DRUG:HS-20094 Placebo Injection
Results posted: FALSE

Registered primary outcomes

Change in HbA1c [Week 0 to Week 44]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.